1,2-dipalmitoylphosphatidylglycerol has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boulikas, T; Darli, E; Deliconstantinos, G; Rigatos, S; Stathopoulos, GP; Stathopoulos, JG; Viliotou, V; Vougiouka, M | 1 |
1 trial(s) available for 1,2-dipalmitoylphosphatidylglycerol and Carcinoma, Epidermoid
Article | Year |
---|---|
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Carcinoma, Squamous Cell; Cholesterol; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Kinetics; Lipids; Liposomes; Male; Middle Aged; Nanotechnology; Pancreatic Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Stomach Neoplasms; Time Factors | 2005 |